Appendix H
Membership of Oversight Boards and Committees

COMMITTEE ON SCIENCE, TECHNOLOGY, AND LAW

DONALD KENNEDY (NAS/IOM), (Co-Chair), President Emeritus and Bing Professor of Environmental Science Emeritus, Stanford University; Emeritus Editor-in-Chief, Science

RICHARD A. MERRILL (IOM), (Co-Chair), Daniel Caplin Professor of Law Emeritus, University of Virginia Law School

FREDERICK R. ANDERSON, JR., Partner, McKenna, Long & Aldridge LLP

ARTHUR I. BIENENSTOCK, Special Assistant to the President for SLAC and Federal Research Policy, Stanford University

BARBARA E. BIERER, Senior Vice President for Research, Brigham and Women’s Hospital

ELIZABETH H. BLACKBURN (NAS/IOM), Morris Herzstein Professor of Biology and Physiology, Department of Biochemistry and Biophysics, University of California, San Francisco

JOE S. CECIL, Project Director, Program on Scientific and Technical Evidence, Federal Judicial Center

RICHARD F. CELESTE, President, Colorado College

JOEL E. COHEN (NAS), Abby Rockefeller Mauzé Professor and Head, Laboratory of Populations, The Rockefeller University and Columbia University

ROCHELLE COOPER DREYFUSS, Pauline Newman Professor of Law and Director, Engelberg Center on Innovation Law and Policy, New York University School of Law

ALICE P. GAST (NAE), President, Lehigh University

LAWRENCE O. GOSTIN (IOM), Associate Dean for Research and Academic Programs, Linda D. and Timothy J. O’Neill Professor



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 83
Appendix H Membership of Oversight Boards and Committees COMMITTEE ON SCIENCE, TECHNOLOGy, AND LAW DONALD KENNEDy (NAS/IOM), (Co-Chair), President Emeritus and Bing Professor of Environmental Science Emeritus, Stanford University; Emeritus Editor-in-Chief, Science RICHARD A. MERRILL (IOM), (Co-Chair), Daniel Caplin Professor of Law Emeritus, University of Virginia Law School FREDERICK R. ANDERSON, JR., Partner, McKenna, Long & Aldridge LLP ARTHUR I. BIENENSTOCK, Special Assistant to the President for SLAC and Federal Research Policy, Stanford University BARBARA E. BIERER, Senior Vice President for Research, Brigham and Women’s Hospital ELIZABETH H. BLACKBURN (NAS/IOM), Morris Herzstein Professor of Biology and Physiology, Department of Biochemistry and Biophysics, University of California, San Francisco JOE S. CECIL, Project Director, Program on Scientific and Technical Evidence, Federal Judicial Center RICHARD F. CELESTE, President, Colorado College JOEL E. COHEN (NAS), Abby Rockefeller Mauzé Professor and Head, Laboratory of Populations, The Rockefeller University and Columbia University ROCHELLE COOPER DREyFUSS, Pauline Newman Professor of Law and Director, Engelberg Center on Innovation Law and Policy, New York University School of Law ALICE P. GAST (NAE), President, Lehigh University LAWRENCE O. GOSTIN (IOM), Associate Dean for Research and Academic Programs, Linda D. and Timothy J. O’Neill Professor 

OCR for page 83
 APPENDIX H of Global Health Law, and Faculty Director, O’Neill Institute for National and Global Health Law, Georgetown University; Professor of Public Health, The Johns Hopkins University; Director of the Center for Law & the Public’s Health, The Johns Hopkins and Georgetown Universities GARy W. HART, Wirth Chair Professor, School of Public Affairs, University of Colorado, Denver BENJAMIN W. HEINEMAN, JR., Senior Fellow, Harvard Law School and Harvard Kennedy School of Government DAVID BROCK HORNBy, Judge, U.S. District Court, District of Maine DAVID KORN (IOM), Chief Scientific Officer, Association of American Medical Colleges RICHARD A. MESERVE (NAE), President, Carnegie Institution for Science and Senior Of Counsel, Covington & Burling, LLP DUNCAN T. MOORE (NAE), Professor, The Institute of Optics, University of Rochester ALAN B. MORRISON, Attorney, Fail Elections Legal Network HARRIET RABB, Vice President and General Counsel, Rockefeller University PAUL D. RHEINGOLD, Senior Partner, Rheingold, Valet, Rheingold, Shkolnik & McCartney LLP BARBARA ROTHSTEIN, Director, Federal Judicial Center JONATHAN M. SAMET (IOM), Professor and Chairman, Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health DAVID S. TATEL, Judge, U.S. Court of Appeals for the District of Columbia Staff ANNE-MARIE MAZZA, Director GURUPRASAD MADHAVAN, Program Officer (until November 2010) STEVEN KENDALL, Senior Program Associate

OCR for page 83
 APPENDIX H BOARD ON LIFE SCIENCES KEITH R. yAMAMOTO (NAS/IOM), (Chair), Professor of Cellular and Molecular Pharmacology and Executive Vice Dean, School of Medicine, University of California, San Francisco ANN M. ARVIN (IOM), Lucile Packard Professor in Pediatrics and Microbiology & Immunology and Vice Provost and Dean of Research, Stanford University School of Medicine BONNIE L. BASSLER (NAS), Howard Hughes Medical Institute Investigator and Squibb Professor of Molecular Biology, Princeton University VICKI L. CHANDLER (NAS), Chief Program Officer for Science, Gordon and Betty Moore Foundation and Regents’ Professor, Departments of Plant Sciences and Molecular & Cellular Biology, University of Arizona SEAN EDDy, Group Leader, Janelia Farm Research Campus, Howard Hughes Medical Institute MARK D. FITZSIMMONS, Associate Director, MacArthur Fellows Program, John D. and Catherine T. MacArthur Foundation DAVID R. FRANZ, Vice President and Chief Biological Scientist, Midwest Research Institute and Senior Advisor, Office of the Assistant to the Secretary of Defense for Nuclear, Chemical and Biological Defense Programs LOUIS J. GROSS, James R. Cox Professor in Ecology and Evolutionary Biology and Mathematics and Director, The Institute for Environmental Modeling, University of Tennessee; and Director, National Institute for Mathematical and Biological Synthesis JO HANDELSMAN, Howard Hughes Medical Institute Professor and Chair, Department of Bacteriology, University of Wisconsin–Madison CATO T. LAURENCIN (IOM), Van Dusen Endowed Chair in Academic Medicine, Distinguished Professor of Orthopaedic Surgery, and Vice President for Health Affairs, University of Connecticut Health Center; and Dean, University of Connecticut School of Medicine, University of Connecticut Health Center JONATHAN D. MORENO (IOM), David and Lyn Silfen University Professor of Ethics and Professor of Medical Ethics and of History and Sociology of Science, University of Pennsylvania; and Senior Fellow, Center for American Progress

OCR for page 83
6 APPENDIX H ROBERT M. NEREM (NAE/IOM), Robert H. Petit Distinguished Chair for Engineering in Medicine and Institute Professor and Director, Parker H. Petit Institute for Bioengineering and Bioscience; and Director, Georgia Tech/Emory Center for the Engineering of Living Tissue, Georgia Institute of Technology CAMILLE PARMESAN, Associate Professor of Integrative Biology, University of Texas at Austin MURIEL E. POSTON, Dean of the Faculty and Professor of Biology, Skidmore College ALISON G. POWER, Dean of the Graduate School and Professor of Ecology and Evolutionary Biology and of Science & Technology Studies, Cornell University BRUCE W. STILLMAN (NAS), President and Chief Executive Officer, Cold Spring Harbor Laboratory CyNTHIA WOLBERGER, Howard Hughes Medical Institute Investigator and Professor of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine MARy WOOLLEy (IOM), President and Chief Executive Officer, Research!America Staff FRANCES E. SHARPLES, Director JO L. HUSBANDS, Scholar/Senior Project Director ADAM P. FAGEN, Senior Program Officer ANN H. REID, Senior Program Officer MARILEE K. SHELTON-DAVENPORT, Senior Program Officer INDIA HOOK-BARNARD, Program Officer ANNA FARRAR, Financial Associate AMANDA P. CLINE, Senior Program Assistant (until May 2010) REBECCA L. WALTER, Senior Program Assistant CARL-GUSTAV ANDERSON, Program Assistant

OCR for page 83
 APPENDIX H FORUM ON DRUG DISCOVERy, DEVELOPMENT, AND TRANSLATION GAIL CASSELL (IOM), (Co-Chair), Vice President, Scientific Affairs and Distinguished Lilly Research Scholar for Infectious Diseases, Eli Lilly and Company JEFFREy DRAZEN (IOM), (Co-Chair), Editor-in-Chief, New England Journal of Medicine BARBARA ALVING, Director, National Center for Research Resources, National Institutes of Health LESLIE BENET (IOM), Professor, Department of Biopharmaceutical Sciences, School of Pharmacy, University of California, San Francisco ANN BONHAM, Chief Scientific Officer, Association of American Medical Colleges CATHERINE BONUCCELLI, Vice President, Development Projects, Symbicort, AstraZeneca Pharmaceuticals LINDA BRADy, Director, Division of Neuroscience and Basic Behavioral Science, National Institute of Mental Health ROBERT CALIFF, Director, Duke Translational Medicine Institute, Professor of Medicine and Vice Chancellor for Clinical and Translational Research, Duke University Medical Center SCOTT CAMPBELL, National Vice President, American Diabetes Association C. THOMAS CASKEy (NAS/IOM), Chief Operating Officer and Director/CEO, University of Texas HSC at Houston PETER CORR, Co-Founder and General Partner, Celtic Therapeutics LLLP JAMES DOROSHOW, Director, Division of Cancer Treatment and Diagnosis, National Cancer Institute PAUL EISENBERG, Senior Vice President, Global Regulatory Affairs and Safety, Amgen Inc. GARy FILERMAN, Senior Vice President and Chairman, Health Management and Policy Group, ATLAS Research GARRET FITZGERALD (IOM), Professor of Medicine, Professor and Chair of Pharmacology, Department of Pharmacology, University of Pennsylvania School of Medicine ELAINE GALLIN, Director, Medical Research Programs, Doris Duke Charitable Foundation

OCR for page 83
 APPENDIX H STEVEN GALSON, Senior Vice President, Science Operations International Corporation MIKHAIL GISHIZKy, Chief Scientific Officer, Entelos, Inc. HARRy GREENBERG, Senior Associate Dean for Research, Joseph D. Grant Professor of Medicine and Microbiology & Immunology, Stanford University School of Medicine STEPHEN GROFT, Director, Office of Rare Disease Research, National Institutes of Health PETER HONIG, Former Executive Vice President for Worldwide Regulatory Affairs and Product Safety within Development, Merck Research Laboratories ANNALISA JENKINS, Senior Vice President Global Medical, Bristol Myers Squibb MICHAEL KATZ (IOM), Senior Vice President for Research and Global Programs, March of Dimes Foundation JACK KEENE, James B. Duke Professor, Molecular Genetics & Microbiology, Duke University Medical Center RONALD KRALL, Senior Vice President and Chief Medical Officer, GlaxoSmithKline FREDA LEWIS-HALL, Chief Medical Officer, SVP, Pfizer WILLIAM MATTHEW, Director of Translational Research, NINDS National Institutes of Health MARK MCCLELLAN (IOM), Director, Engelberg Center for Health Care Reform, The Brookings Institution CAROL MIMURA, Assistant Vice Chancellor for Intellectual Property & Industry Research Alliances (IPIRA), University of California, Berkeley JOHN ORLOFF, Senior Vice President, US Medical & Drug Regulatory Affairs, Novartis Pharmaceuticals Corporation AMy PATTERSON, Acting Director, Office of Science Policy, National Institutes of Health JANET SHOEMAKER, Director, Office of Public Affairs, American Society for Microbiology LANA SKIRBOLL, Acting Director, Division of Program Coordination, Planning, and Strategic Initiatives, National Institutes of Health NANCy SUNG, Senior Program Officer, Burroughs-Wellcome Fund JORGE TAVEL, Deputy Director, Division of Clinical Research, National Institute of Allergy and Infectious Diseases JANET TOBIAS, President Sierra/Tango Productions, Ikana Media

OCR for page 83
 APPENDIX H JOANNE WALDSTREICHER, Head of Global Development, CNS/ IM Franchise JANET WOODCOCK, Deputy Commissioner and Chief Medical Officer, U.S. Food and Drug Administration RAyMOND WOOSLEy, President and CEO, The Critical Path Institute Staff ROBERT GIFFIN, Forum Director (until February 2010) SALLy CLUCHEy, Program Officer (until October 2009)

OCR for page 83
0 APPENDIX H ROUNDTABLE ON TRANSLATING GENOMIC-BASED RESEARCH FOR HEALTH WyLIE BURKE, (IOM), (Chair), Professor and Chair, Department of Bioethics and Humanities, University of Washington BRUCE BLUMBERG, Co-Chief of Medical Genetics, Kaiser- Permanente, Oakland, and Institutional Director of Graduate Medical Education, Northern California Kaiser Permanente DENISE E. BONDS, Medicial Director, Division of Prevention & Population Sciences, National Heart, Lung, and Blood Institute C. THOMAS CASKEy (NAS/IOM), Director and Chief Executive Officer, The George & Cynthia Mitchell Distinguished Chair in Neurosciences and Executive Vice President of Molecular Medicine and Genetics, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston STEPHEN ECK, Vice President, Translational Medicine & Pharmacogenomics, Eli Lilly and Company ANDREW N. FREEDMAN, Genetic Epidemiologist, Risk Factor Monitoring and Methods Branch, Division of Cancer Control and Population Sciences, National Cancer Institute GEOFFREy GINSBURG, Director, Center for Genomic Medicine, Institute for Genomic Sciences & Policy, Duke University R. RODNEy HOWELL, Special Assistant to the Director, National Institute of Child Health and Human Development KATHy HUDSON, Director, Genetics and Public Policy Center, Johns Hopkins Berman Institute of Bioethics (until July 2009) SHARON KARDIA, Director, Public Health Genetic Programs Associate Professor, Department of Epidemiology, University of Michigan, School of Public Health MOHAMED KHAN, Associate Director of Translational Research Department of Radiation Medicine, Roswell Park Cancer Institute MUIN KHOURy, Director, National Office of Public Health Genomics, Centers for Disease Control and Prevention ALLAN KORN, Chief Medical Officer, Senior Vice President Clinical Affairs, BlueCross/BlueShield Association DEBRA LEONARD, Professor and Vice Chair of Laboratory Medicine Director of the Clinical Laboratories, Weill Cornell Medical Center MICHELE LLOyD-PURyEAR, Chief, Genetic Services Branch, Health Resources and Services Administration

OCR for page 83
 APPENDIX H ELIZABETH MANSFIELD, Director of Personalized Medicine, Office of In Vitro Diagnostic Device Evaluation and Safety, Center for Devices and Radiological Health, U.S. Food and Drug Administration GARRy NEIL, Corporate Vice President, Corporate Office of Science and Technology (COSAT), Johnson & Johnson ROBERT L. NUSSBAUM (IOM), Chief, Division of Medical Genetics, Department of Medicine & Institute of Human Genetics, University of California, San Francisco, School of Medicine KIMBERLy J. POPOVITS, President and CEO, Genomic Health, Inc. AIDAN POWER, Vice President and Global Head of Molecular Medicine, Pfizer, Inc. RONALD PRZyGODZKI, Associate Director for Genomic Medicine Biomedical Laboratory Research and Development, Department of Veterans Affairs AMELIE G. RAMIREZ (IOM), Dielmann Chair, Health Disparities and Community Outreach Research and Director, Institute for Health Promotion Research, University of Texas Health Science Center at San Antonio LAURA LyMAN RODRIGUEZ, Senior Advisor to the Director for Research Policy, National Human Genome Research Institute ALLEN D. ROSES (IOM), Jefferson-Pilot Professor of Neurobiology and Genetics, Professor of Medicine, Director, Deane Drug Discovery Institute, and Senior Scholar, Fuqua School of Business R. David Thomas Executive Training Center, Duke University KEVIN A. SCHULMAN, Professor of Medicine & Business Administration; Director, Center for Clinical and Genetic Economics; and Associate Director, Duke Clinical Research Institute, Duke University Medical Center SHARON TERRy, President and CEO, Genetic Alliance STEVEN TEUTSCH, Representative, Secretary’s Advisory Committee on Genetics, Health and Society MARTHA TURNER, Assistant Director, Center for Ethics and Human Rights, American Nurses Association MICHAEL S. WATSON, Executive Director, American College of Medical Genetics CATHERINE A. WICKLUND, Director, Graduate Program in Genetic Counseling; Immediate Past President, National Society of Genetic Counselors; and Assistant Professor, Department of Obstetrics and Gynecology, Northwestern University

OCR for page 83
 APPENDIX H Staff LyLA HERNANDEZ, Staff Director (until March 2010) ADAM BERGER, Project Director (from March 2010) ERIN HAMMERS, Research Associate ALEX REPACE, Senior Project Assistant

OCR for page 83
 APPENDIX H NATIONAL CANCER POLICy FORUM HAROLD MOSES (IOM), (Chair), Director Emeritus, Vanderbilt- Ingram Cancer Center FRED APPELBAUM, Director, Clinical Research Division, Fred Hutchinson Cancer Research Center PETER BACH, Associate Attending Physician, Memorial Sloan- Kettering Cancer Center EDWARD BENZ, JR., President, Dana Farber Cancer Institute THOMAS BURISH, Past-Chair, American Cancer Society Board of Directors and Provost, Notre Dame University MICHAELE CHAMBLEE CHRISTIAN, Former Director, Division of Cancer Treatment and Diagnosis, National Cancer Institute ROBERT ERWIN, President, Marti Nelson Cancer Foundation BETTy FERRELL, Research Scientist, City of Hope National Medical Center JOSEPH FRAUMENI, JR., Director, Division of Cancer Epidemiology and Genetics, National Cancer Institute PATRICIA GANZ, Professor of Health Services, School of Public Health and Professor of Medicine, David Geffen School of Medicine, University of California, Los Angeles ROBERT GERMAN, Associate Director for Science, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention ROy HERBST, Chief, Thoracic/Head & Neck Medical Oncology, M.D. Anderson Cancer Center THOMAS KEAN, Executive Director, C-Change JOHN MENDELSOHN, President, M.D. Anderson Cancer Center JOHN NIEDERHUBER, Director, National Cancer Institute DAVID PARKINSON, President and CEO, Oncology Research and Development, Nodality Inc. SCOTT RAMSEy, Member, Cancer Prevention Program, Division of Public Health Science, Fred Hutchinson Cancer Research Center JOHN WAGNER, Executive Director, Clinical Pharmacology, Merck & Company, Inc. JANET WOODCOCK, Deputy Commissioner and Chief Medical Officer, U.S. Food and Drug Administration Staff ROGER HERDMAN, Director (until September 2009) ADAM SCHIKEDANZ, Staff (until June 2009)

OCR for page 83